+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiac Biomarker Market by Biomarker Type (BNP & NT-proBNP, Creatine Kinase (CK) MB, Myoglobin), Clinical Setting (Laboratory Testing, Point Of Care Testing), Application, End User - Global Forecast 2025-2030- Product Image
Cardiac Biomarker Market by Biomarker Type (BNP & NT-proBNP, Creatine Kinase (CK) MB, Myoglobin), Clinical Setting (Laboratory Testing, Point Of Care Testing), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Cardiac Biomarker Market by Biomarker Type (BNP & NT-proBNP, Creatine Kinase (CK) MB, Myoglobin), Clinical Setting (Laboratory Testing, Point Of Care Testing), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011195
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cardiac Biomarker Market is evolving rapidly in response to rising clinical needs and technological advancements, positioning itself as a focal point for innovation within the cardiovascular diagnostics industry. Senior decision-makers require actionable insights to effectively navigate opportunities, potential disruptions, and strategic growth areas in this sector.

Market Snapshot: Cardiac Biomarker Market

The cardiac biomarker market grew from USD 13.26 billion in 2024 to USD 14.41 billion in 2025. It is expected to continue growing at a CAGR of 9.10%, reaching USD 22.37 billion by 2030. This expansion is driven by increasing demand for precision diagnostics in cardiovascular medicine, ongoing innovations in biomarker assays, and a growing emphasis on early detection and risk stratification in clinical practice. Enhanced sensitivity and accessibility have broadened the clinical utility and adoption of cardiac biomarker testing worldwide.

Scope & Segmentation

  • Biomarker Types: BNP & NT-proBNP, Creatine Kinase (CK) MB, Myoglobin, Troponins
  • Clinical Settings: Laboratory Testing, Point Of Care Testing
  • Applications: Diagnosis (Acute Coronary Syndrome, Congestive Heart Failure, Myocardial Infarction), Prognosis, Risk Assessment
  • End Users: Diagnostic Laboratories, Hospitals & Clinics, Research Institutes
  • Geographies Covered: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the United Kingdom, Germany, France, Russia, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, and other prominent countries)
  • Leading Companies Profiled: Abbott Laboratories, Abcam plc, Becton Dickinson and Company, Bio-Rad Laboratories Inc., bioMérieux SA, Danaher Corporation, DiaSorin S.p.A., Epitope Diagnostics Inc., F. Hoffmann-La Roche AG, Fujirebio Diagnostics Inc., Guangzhou Wondfo Biotech Co., Ltd., Hologic Inc., Johnson & Johnson Services, Inc., Life Diagnostics Inc., LSI Medience Corporation, Meridian Bioscience Inc., Myriad RBM Inc., PerkinElmer Inc., Quest Diagnostics Incorporated, Quidel Corporation, QuidelOrtho Corporation, Randox Laboratories Limited, Sekisui Medical Co., Ltd., Siemens Healthineers AG, Singulex Inc., Sysmex Corporation, Thermo Fisher Scientific Inc., Tosoh Corporation, Trinity Biotech plc
  • Technologies & Innovations: Next-generation immunoassays, multiplex platforms, point-of-care analyzers, digital health integrations, artificial intelligence–enabled risk models

Key Takeaways

  • The market’s transition toward decentralized and point-of-care testing is enabling faster, more accessible diagnostics in both acute and outpatient environments.
  • Advances in assay sensitivity now allow for earlier detection of cardiac injury, empowering clinicians with actionable data for timely intervention and risk stratification.
  • Digital integration and AI-driven analytics are refining clinical workflows, assisting in personalized care pathways and supporting resource allocation across healthcare systems.
  • Clinical adoption patterns vary, with some geographies prioritizing rapid diagnostics and others emphasizing comprehensive laboratory-based panels depending on infrastructure maturity.
  • Collaborations between established conglomerates and nimble technology specialists are accelerating innovation, enhancing the breadth and quality of diagnostic offerings in the market.
  • Continuous adaptation to evolving regulatory and reimbursement requirements remains critical for long-term competitive success in this dynamic landscape.

Tariff Impact: Navigating Trade Policy Disruptions

Recent changes to United States tariff measures have directly influenced cardiac biomarker supply chains and cost structures. Manufacturers have adapted by reevaluating sourcing strategies, localizing production, and diversifying portfolios to offset higher duties on imported assay reagents and diagnostic instruments. Distributors and suppliers are now emphasizing regional manufacturing initiatives, joint ventures, and alternative sourcing to maintain operational resilience and preserve value for both laboratories and care providers.

Methodology & Data Sources

This report utilizes a robust mixed-method approach, combining primary interviews with clinical, regulatory, and industry experts, and comprehensive secondary research drawn from peer-reviewed publications, industry reports, and government databases. Segmentation modeling applies bottom-up analysis, while data integrity is ensured through triangulation, peer reviews, and systematic audits.

Why This Report Matters

  • Offers strategic guidance for investment, product development, and geographic expansion in the cardiac biomarker space.
  • Enables identification of growth opportunities and risk factors unique to each segment and region for informed portfolio and resource allocation decisions.

Conclusion

The cardiac biomarker market is undergoing transformative growth, fueled by technology, complex policy environments, and shifting healthcare priorities. This report provides strategic direction for industry leaders seeking to navigate emerging challenges and harness new opportunities in cardiovascular diagnostics.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of high-sensitivity troponin assays enabling earlier myocardial infarction detection and risk stratification
5.2. Integration of point-of-care cardiac biomarker testing with telemedicine platforms for remote patient monitoring
5.3. Expansion of multiplex biomarker panels combining NT-proBNP, troponin, and inflammatory markers for improved heart failure diagnosis
5.4. Development of ultra-sensitive digital immunoassays for subclinical cardiotoxicity assessment in oncology patients
5.5. Emergence of AI-driven predictive algorithms using longitudinal biomarker data to forecast acute cardiac events
5.6. Regulatory approvals of novel cardiac biomarker assays driving reimbursement and broader clinical adoption
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cardiac Biomarker Market, by Biomarker Type
8.1. Introduction
8.2. BNP & NT-proBNP
8.3. Creatine Kinase (CK) MB
8.4. Myoglobin
8.5. Troponins
9. Cardiac Biomarker Market, by Clinical Setting
9.1. Introduction
9.2. Laboratory Testing
9.3. Point Of Care Testing
10. Cardiac Biomarker Market, by Application
10.1. Introduction
10.2. Diagnosis
10.2.1. Acute Coronary Syndrome
10.2.2. Congestive Heart Failure
10.2.3. Myocardial Infarction
10.3. Prognosis
10.4. Risk Assessment
11. Cardiac Biomarker Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Hospitals & Clinics
11.4. Research Institutes
12. Americas Cardiac Biomarker Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cardiac Biomarker Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cardiac Biomarker Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Abbott Laboratories
15.3.2. Abcam plc
15.3.3. Becton, Dickinson and Company
15.3.4. Bio-Rad Laboratories Inc.
15.3.5. bioMérieux SA
15.3.6. Danaher Corporation
15.3.7. DiaSorin S.p.A.
15.3.8. Epitope Diagnostics Inc.
15.3.9. F. Hoffmann-La Roche AG
15.3.10. Fujirebio Diagnostics Inc.
15.3.11. Guangzhou Wondfo Biotech Co., Ltd.
15.3.12. Hologic Inc.
15.3.13. Johnson & Johnson Services, Inc.
15.3.14. Life Diagnostics, Inc.
15.3.15. LSI Medience Corporation
15.3.16. Meridian Bioscience, Inc.
15.3.17. Myriad RBM Inc.
15.3.18. PerkinElmer, Inc.
15.3.19. Quest Diagnostics Incorporated
15.3.20. Quidel Corporation
15.3.21. QuidelOrtho Corporation
15.3.22. Randox Laboratories Limited
15.3.23. Sekisui Medical Co., Ltd.
15.3.24. Siemens Healthineers AG
15.3.25. Singulex, Inc.
15.3.26. Sysmex Corporation
15.3.27. Thermo Fisher Scientific Inc.
15.3.28. Tosoh Corporation
15.3.29. Trinity Biotech plc
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CARDIAC BIOMARKER MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CARDIAC BIOMARKER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CARDIAC BIOMARKER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CARDIAC BIOMARKER MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CARDIAC BIOMARKER MARKET: RESEARCHAI
FIGURE 24. CARDIAC BIOMARKER MARKET: RESEARCHSTATISTICS
FIGURE 25. CARDIAC BIOMARKER MARKET: RESEARCHCONTACTS
FIGURE 26. CARDIAC BIOMARKER MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CARDIAC BIOMARKER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIAC BIOMARKER MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CARDIAC BIOMARKER MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY BNP & NT-PROBNP, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY BNP & NT-PROBNP, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY CREATINE KINASE (CK) MB, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY CREATINE KINASE (CK) MB, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY MYOGLOBIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY TROPONINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY TROPONINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY PROGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY PROGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 73. CANADA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 74. CANADA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 75. CANADA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 76. CANADA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 77. CANADA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. CANADA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. CANADA CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 80. CANADA CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 81. CANADA CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. CANADA CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 84. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 85. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 86. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 87. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 90. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 91. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 136. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 137. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 138. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 139. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 142. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 143. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 146. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 147. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 148. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 149. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 152. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 153. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 163. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. ITALY CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 166. ITALY CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 167. ITALY CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 168. ITALY CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 169. ITALY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. ITALY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. ITALY CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 172. ITALY CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 173. ITALY CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. ITALY CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 176. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 177. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 178. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 179. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 182. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 183. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 216. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 217. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 218. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 219. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 222. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 223. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 233. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. QATAR CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 236. QATAR CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 237. QATAR CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 238. QATAR CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 239. QATAR CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. QATAR CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. QATAR CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 242. QATAR CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 243. QATAR CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. QATAR CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 246. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 247. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 248. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 249. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 252. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 253. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 263. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 273. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 276. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 277. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 278. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 279. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 282. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 283. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 286. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 287. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 288. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 289. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 292. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 293. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 303. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 306. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 307. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 308. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 309. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 312. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 313. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. POLAND CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 316. POLAND CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 317. POLAND CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 318. POLAND CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 319. POLAND CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. POLAND CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. POLAND CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 322. POLAND CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 323. POLAND CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. POLAND CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 326. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 327. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 328. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 329. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 330. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 331. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 332. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 333. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 336. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 338. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 339. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 340. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 341. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 342. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 343. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 345. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 346. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 347. CHINA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 348. CHINA CARDIAC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 349. CHINA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 350. CHINA CARDIAC BIOMARKER MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 351. CHINA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 352. CHINA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 353. CHINA CARDIAC BIOMARKER MARKET SIZE, BY DIAGNOSIS, 2018-2024

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • Abcam plc
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Epitope Diagnostics Inc.
  • F. Hoffmann-La Roche AG
  • Fujirebio Diagnostics Inc.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • Hologic Inc.
  • Johnson & Johnson Services, Inc.
  • Life Diagnostics, Inc.
  • LSI Medience Corporation
  • Meridian Bioscience, Inc.
  • Myriad RBM Inc.
  • PerkinElmer, Inc.
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • QuidelOrtho Corporation
  • Randox Laboratories Limited
  • Sekisui Medical Co., Ltd.
  • Siemens Healthineers AG
  • Singulex, Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Trinity Biotech plc

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 14.41 Billion
Forecasted Market Value ( USD ) by 2030 $ 22.37 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Cardiac Biomarker Diagnostic Kits Market by Biomarker Type (B-Type Natriuretic Peptide, C-Reactive Protein, Cardiac Troponin), Indication (Angina Pectoris, Heart Failure, Myocardial Infarction), Testing Type, Purchasing Mode, Application, End User - Global Forecast 2025-2030 - Product Image

Cardiac Biomarker Diagnostic Kits Market by Biomarker Type (B-Type Natriuretic Peptide, C-Reactive Protein, Cardiac Troponin), Indication (Angina Pectoris, Heart Failure, Myocardial Infarction), Testing Type, Purchasing Mode, Application, End User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Cardiac Biomarkers Market Size, Share & Trends Analysis Report by Type (Troponin, CK-MB, Myoglobin, BNP and NT-proBNP, Others), Application, End-use, and Region with Growth Forecasts, 2025-2030 - Product Image

Cardiac Biomarkers Market Size, Share & Trends Analysis Report by Type (Troponin, CK-MB, Myoglobin, BNP and NT-proBNP, Others), Application, End-use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Cardiac Biomarker Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Cardiac Biomarker Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 92 Pages
  • Global
From
Cardiac Marker Analyzer Market by Assay Type, Technology, End User, Application - Global Forecast to 2030 - Product Image

Cardiac Marker Analyzer Market by Assay Type, Technology, End User, Application - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Cardiac Biomarkers - Global Strategic Business Report - Product Image

Cardiac Biomarkers - Global Strategic Business Report

  • Report
  • 272 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.